Risk of cardiovascular events according to the tricyclic antidepressant dosage in patients with chronic pain: a retrospective cohort study.
Hyunji KooSeung-Hun YouSewon ParkKyeong Hye JeongNakyung JeonSun-Young JungPublished in: European journal of clinical pharmacology (2022)
Close monitoring of patients on long-term, low-dose use of TCAs should be conducted to avoid an increase in the cumulative dose, which increases the risk of cardiovascular adverse events.